Cutler Group’s BELLUS Health Inc. BLU Stock Holding History

Cutler Group’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,100	Closed	-$3K	–	5955
2022 Q1	$3K	Sell	2,100 -6,700	-76%	-$43.2K	﹤0.01%	4583
2021 Q4	$5K	Buy	+8,800	New	+$58.4K	﹤0.01%	4260

Other funds holding BLU

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cutler Group's BLU Position: Q3 2022 in Review

Cutler Group sold out of BELLUS Health Inc. (BLU) in Q3 2022, closing a stake of 2,100 shares — an estimated $19K sold.

Cutler Group first reported a position in BLU in Q2 2022 and held it in 1 quarter. The position peaked at $19K in Q2 2022. 116 funds tracked by Wall St. Rank hold BLU as of Q3 2022.

Cutler Group reported no remaining BELLUS Health Inc. position as of Q3 2022 after selling out during the quarter.
Cutler Group sold 2,100 BELLUS Health Inc. shares in Q3 2022, an estimated $19K.
Cutler Group first reported a position in BELLUS Health Inc. in Q2 2022 and held it in 1 quarter.
Cutler Group's BELLUS Health Inc. position peaked at $19K in Q2 2022.
116 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.